RGEN
Repligen
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: RGEN
- PE Ratio
The current PE ratio for Repligen stock as of Jun 23, 2026 is 137.36. This is calculated based on the current EPS of $0.92 and the stock price of $126.37 per share.
RGEN PE ratio history
The average historical PE ratio of Repligen for the last ten years is 327.64. The current PE ratio of 137.36 is 58% below the historical average. Over the past ten years, RGEN's PE ratio was at its highest in the Sep 2025 quarter at 6,683.5, when the stock price was $133.67 and the EPS was $0.02. The lowest value was in the Mar 2018 quarter, when it reached 48.89 with a price of $36.18 and an EPS of $0.74.
Repligen PE ratio by year
Maximum annual increase: 455.88% in 2023
Maximum annual decrease: -55.54% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 188.34 | N/A | $163.86 | $0.87 |
| 2024 | N/A | N/A | $143.94 | -$0.46 |
| 2023 | 280.94 | 455.88% | $179.8 | $0.64 |
| 2022 | 50.54 | -55.54% | $169.31 | $3.35 |
| 2021 | 113.67 | -32.38% | $264.84 | $2.33 |
| 2020 | 168.1 | -20.04% | $191.63 | $1.14 |
| 2019 | 210.23 | 51.47% | $92.5 | $0.44 |
| 2018 | 138.79 | 183.07% | $52.74 | $0.38 |
| 2017 | 49.03 | -44.32% | $36.28 | $0.74 |
| 2016 | 88.06 | -12.85% | $30.82 | $0.35 |
| 2015 | 101.04 | 27.58% | $28.29 | $0.28 |
| 2014 | 79.2 | 196.07% | $19.8 | $0.25 |
| 2013 | 26.75 | 95.97% | $13.64 | $0.51 |
| 2012 | 13.65 | N/A | $6.28 | $0.46 |
| 2011 | N/A | N/A | $3.74 | $0 |
Repligen PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 128.07 | -32% | $117.82 | $0.92 |
| Dec 2025 | 188.34 | -97.18% | $163.86 | $0.87 |
| Sep 2025 | 6,683.5 | N/A | $133.67 | $0.02 |
| Jun 2025 | N/A | N/A | $124.38 | -$0.26 |
| Mar 2025 | N/A | N/A | $127.24 | -$0.42 |
| Dec 2024 | N/A | N/A | $143.94 | -$0.46 |
| Sep 2024 | N/A | N/A | $148.82 | -$0.14 |
| Jun 2024 | 741.53 | 73.37% | $126.06 | $0.17 |
| Mar 2024 | 427.72 | 52.25% | $183.92 | $0.43 |
| Dec 2023 | 280.94 | 219.8% | $179.8 | $0.64 |
| Sep 2023 | 87.85 | 39.11% | $159.01 | $1.81 |
| Jun 2023 | 63.15 | 4.28% | $141.46 | $2.24 |
| Mar 2023 | 60.56 | 19.83% | $168.36 | $2.78 |
| Dec 2022 | 50.54 | -18.97% | $169.31 | $3.35 |
| Sep 2022 | 62.37 | 10.6% | $187.11 | $3 |
RGEN Price vs fair value
RGEN average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
RGEN's current P/E ratio is below the 3, 5 and 10-year averages.
PE comparison
Repligen's P/E of 137.36 is above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 23.78, Repligen's P/E is 478% higher.
RGEN PE vs peers
Compared to its peer stocks GE and TMO, RGEN's PE ratio stands higher. Repligen's PE ratio is trading above the peer group average of 28.03.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BMY Bristol Myers Squibb Co | 15.55 | $113.4B |
| PFE Pfizer Inc | 18.87 | $140.89B |
| NBIX Neurocrine Biosciences Inc | 24.06 | $16.23B |
| TMO Thermo Fisher Scientific Inc | 25.76 | $174.42B |
| BMRN Biomarin Pharmaceutical Inc | 40.36 | $10.92B |
| GE General Electric Co | 43.58 | $371.92B |
| TECH BIO-TECHNE Corp | 79.24 | $8.81B |
| RGEN Repligen Corp | 137.36 | $7.13B |
| NVAX Novavax Inc | N/A | $1.48B |
| CRL Charles River Laboratories International Inc | N/A | $8.99B |
Frequently asked questions
What is Repligen's PE ratio?
As of Jun 23, 2026, RGEN stock has a price to earnings ratio of 137.36.
What is the 3-year average PE ratio for Repligen (RGEN)?
Over the last 3 years, the average price to earnings ratio for RGEN stock is 1075.14.
What is the 5-year average PE ratio for Repligen (RGEN)?
Over the last 5 years, the average price to earnings ratio for RGEN stock is 578.52.
What is the highest PE ratio for RGEN?
Over the last ten years, the quarterly PE ratio reached a historic high of 6,683.5 in the Sep 2025 quarter.
How does the current PE ratio for RGEN compare to its historical average?
The current price to earnings ratio of RGEN is 58% lower than the 10-year historical average.
Why is Repligen's PE ratio so high?
RGEN's PE ratio of 137.36 is considered high because the company's stock price is trading at a higher multiple of earnings.
How is RGEN's PE ratio calculated (Repligen PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 23, 2026), Repligen's stock price is $126.37. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.92. Therefore, Repligen's P/E ratio for today is 137.36. PE RATIO(137.36) = STOCK PRICE($126.37) / TTM EPS($0.92)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.